Navigation Systems for Urologic Cancer Surgery

Urologic Lymphadenectomy in AMIGO

Recruiting N/A Interventional Study
Urologic Cancer Lymph Node Metastasis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
20 (estimated)
Sponsor
Brigham and Women's Hospital · Other
Who this trial is looking for

This trial is looking for adults with urologic cancer who are scheduled for a specific type of surgery to remove lymph nodes. Participants will use advanced navigation systems to guide the surgery.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old.
  • I have a confirmed or suspected diagnosis of urologic cancer.
  • I have had a recent CT, PET, or MR scan at Brigham and Women's Hospital.
  • I am scheduled to have lymphadenectomy for urologic cancer.
  • I will undergo laparoscopic lymphadenectomy in the AMIGO operating room.
  • I have signed the consent form for the trial.

You may not be able to join if

  • I have severely impaired kidney function.
  • I have a serious medical condition that could affect my participation.
  • I am allergic to contrast media.
  • I cannot have general anesthesia.
  • I am pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This research study involves the use of two navigation systems, the 3D Slicer-based navigation system, and the Siemens Monaco systems, to simplify the complexity of image-guided lymphadenectomy procedures (surgery to remove one or more lymph nodes) in patients with urological cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Signed written informed consent before any trial-related procedure is undertaken that is not part of the standard patient management * Subjects aged ≥ 18 years. Selected patients must have a confirmed or suspected diagnosis of disease in urologic regions of interest, with sche…
Contacts

Matthew Mossanen, MD

(617) 732-6384

mmossanen@bwh.harvard.edu

CONTACT